Changes in butyrylcholinesterase activity in patients with Alzheimer disease treated with acetylcholinesterase inhibitors

被引：0
|
作者：
Sanchez Morillo, J. [1 ]
Estruch Perez, M. J. [1 ]
Barber Ballester, G. [1 ]
Pertusa Collado, V. [1 ]
机构：
[1] Hosp Univ Dr Peset, Serv Anestesiol & Reanimac, Valencia, Spain
来源：
NEUROLOGIA | 2011年 / 26卷 / 04期
关键词：
SUXAMETHONIUM; EDROPHONIUM; NEOSTIGMINE; THERAPY;
D O I：
10.1016/j.nrl.2010.09.025
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：247 / 248
页数：2
相关论文
共 50 条
  • [31] Cardiovascular Complications of Acetylcholinesterase Inhibitors in Patients with Alzheimer's Disease: A Narrative Review
    Young, Sara
    Chung, Enoch
    Chen, Michael A.
    ANNALS OF GERIATRIC MEDICINE AND RESEARCH, 2021, 25 (03): : 170 - 177
  • [32] Acetylcholinesterase inhibitors associated with decreased hip fracture risk in patients with Alzheimer disease
    Nature Reviews Endocrinology, 2012, 8 (6) : 322 - 322
  • [33] Acetylcholinesterase inhibitors and depressive symptoms in patients with mild to moderate Alzheimer's Disease
    Rozzini, Luca
    Chilovi, Barbara Vicini
    Bertoletti, Erik
    Trabucchi, Marco
    Padovani, Alessandro
    AGING CLINICAL AND EXPERIMENTAL RESEARCH, 2007, 19 (03) : 220 - 223
  • [34] Acetylcholinesterase inhibitors and depressive symptoms in patients with mild to moderate Alzheimer's Disease
    Rozzini L.
    Chilovi B.V.
    Bertoletti E.
    Trabucchi M.
    Padovani A.
    Aging Clinical and Experimental Research, 2007, 19 (3) : 220 - 223
  • [35] Molecular docking studies of coumarin hybrids as potential acetylcholinesterase, butyrylcholinesterase, monoamine oxidase A/B and β-amyloid inhibitors for Alzheimer's disease
    Yusufzai, Samina Khan
    Khan, Mohammad Shaheen
    Sulaiman, Othman
    Osman, Hasnah
    Lamjin, Dalily Nabilah
    CHEMISTRY CENTRAL JOURNAL, 2018, 12
  • [36] Discovery of novel dual acetylcholinesterase inhibitors with antifibrillogenic activity related to Alzheimer's disease
    de Almeida, Jonathan R.
    Figueiro, Micheli
    Almeida, Wanda Pereira
    Tomich de Paula da Silva, Carlos Henrique
    FUTURE MEDICINAL CHEMISTRY, 2018, 10 (09) : 1037 - 1053
  • [37] Molecular docking studies of coumarin hybrids as potential acetylcholinesterase, butyrylcholinesterase, monoamine oxidase A/B and β-amyloid inhibitors for Alzheimer’s disease
    Samina Khan Yusufzai
    Mohammad Shaheen Khan
    Othman Sulaiman
    Hasnah Osman
    Dalily Nabilah Lamjin
    Chemistry Central Journal, 12
  • [38] Development of Pyrimidine-Substituted Schiff Base and Their Axially Silicon Phthalocyanines as Inhibitors of Acetylcholinesterase and Butyrylcholinesterase for Alzheimer's Disease Therapy
    Kamiloglu, Ayse Aktas
    Arslan, Tayfun
    Tekin, Askin
    Kantekin, Halit
    APPLIED ORGANOMETALLIC CHEMISTRY, 2025, 39 (04)
  • [39] Acetylcholinesterase inhibitors and nanoparticles on Alzheimer's disease: a review
    Silva, Sara
    Almeida, Antonio J.
    Vale, Nuno
    JOURNAL OF NANOPARTICLE RESEARCH, 2021, 23 (01)
  • [40] Acetylcholinesterase Inhibitors, AMD, and Alzheimer Disease-Reply
    Magagnoli, Joseph
    Sutton, S. Scott
    Ambati, Jayakrishna
    JAMA OPHTHALMOLOGY, 2024, 142 (07) : 684 - 685
12345